DE69910987D1 - Mikrosphären mit verzögerter Wirkstoffabgabe - Google Patents

Mikrosphären mit verzögerter Wirkstoffabgabe

Info

Publication number
DE69910987D1
DE69910987D1 DE69910987T DE69910987T DE69910987D1 DE 69910987 D1 DE69910987 D1 DE 69910987D1 DE 69910987 T DE69910987 T DE 69910987T DE 69910987 T DE69910987 T DE 69910987T DE 69910987 D1 DE69910987 D1 DE 69910987D1
Authority
DE
Germany
Prior art keywords
microspheres
drug delivery
delayed drug
delayed
angstroms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69910987T
Other languages
English (en)
Other versions
DE69910987T2 (de
Inventor
Terence L Scott
Larry R Brown
Frank J Riske
Charles D Blizzard
Julia Rashba-Step
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of DE69910987D1 publication Critical patent/DE69910987D1/de
Application granted granted Critical
Publication of DE69910987T2 publication Critical patent/DE69910987T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
DE69910987T 1999-06-14 1999-06-14 Mikrosphären mit verzögerter Wirkstoffabgabe Expired - Lifetime DE69910987T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99304616A EP1060741B1 (de) 1999-06-14 1999-06-14 Mikrosphären mit verzögerter Wirkstoffabgabe

Publications (2)

Publication Number Publication Date
DE69910987D1 true DE69910987D1 (de) 2003-10-09
DE69910987T2 DE69910987T2 (de) 2004-05-19

Family

ID=8241454

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69910987T Expired - Lifetime DE69910987T2 (de) 1999-06-14 1999-06-14 Mikrosphären mit verzögerter Wirkstoffabgabe

Country Status (4)

Country Link
EP (1) EP1060741B1 (de)
AT (1) ATE248587T1 (de)
DE (1) DE69910987T2 (de)
ES (1) ES2207123T3 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6458387B1 (en) 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
WO2001076553A2 (en) * 2000-04-06 2001-10-18 Sontra Medical, Inc. Method and device for enhanced transdermal drug delivery
WO2002043580A2 (en) 2000-10-27 2002-06-06 Epic Therapeutics, Inc. Production of microspheres
PT1397155E (pt) 2001-06-21 2015-12-07 Genentech Inc Formulação de libertação sustentada
ES2425392T3 (es) 2002-03-20 2013-10-15 Mannkind Corporation Cartucho para un aparato de inhalación
US20050175693A1 (en) * 2002-05-09 2005-08-11 Peptron Co., Ltd Substained release formulation of protein and preparation method thereof
EP1646445A4 (de) * 2003-07-18 2007-09-19 Baxter Int Verfahren zur herstellung, verwendungen und zusammensetzungen von durch kontrollierte phasentrennung hergestellten kleinen kugelförmigen teilchen
CN103432079A (zh) 2004-05-12 2013-12-11 巴克斯特国际公司 含有寡核苷酸的微球体及其在制备用于治疗1型糖尿病的药物中的应用
US8333995B2 (en) 2004-05-12 2012-12-18 Baxter International, Inc. Protein microspheres having injectable properties at high concentrations
DK2072040T3 (da) 2004-05-12 2013-07-29 Baxter Healthcare Sa Terapeutisk anvendelse af nukleinsyremikrokugler
US8728525B2 (en) 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
PL1791542T3 (pl) 2004-08-23 2015-11-30 Mannkind Corp Sole diketopiperazyny do dostarczania leków
AU2006290870B2 (en) 2005-09-14 2013-02-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
AU2014271222B2 (en) * 2005-09-14 2016-04-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
CA2818900C (en) * 2005-09-14 2018-02-06 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
EP2497484A3 (de) 2006-02-22 2012-11-07 MannKind Corporation Verfahren zur Verbesserung der pharmazeutischen Eigenschaften von Mikropartikeln mit Diketopiperazin und einem Wirkstoff
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
MX2009001226A (es) 2006-08-04 2009-03-20 Baxter Int Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
CA2723192A1 (en) 2008-05-07 2009-11-12 Surmodics, Inc. Delivery of nucleic acid complexes from particles
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2570147T3 (da) 2008-06-13 2018-01-29 Mannkind Corp Tørpulverinhalator og system til lægemiddelindgivelse
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8323615B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8323685B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8367427B2 (en) 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US8734845B2 (en) 2009-06-12 2014-05-27 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
MY180552A (en) 2011-04-01 2020-12-02 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
WO2013063160A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
JP6254187B2 (ja) * 2012-12-20 2017-12-27 オムリックス・バイオファーマシューティカルズ・リミテッドＯｍｒｉｘ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． ウイルス不活性化生物学的混合物
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
CN114848614A (zh) 2013-07-18 2022-08-05 曼金德公司 热稳定性干粉药物组合物和方法
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2022008699A1 (en) * 2020-07-09 2022-01-13 F. Hoffmann-La Roche Ag Concentrated compositions of proteins, their preparation and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160745A (en) * 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
US4925677A (en) * 1988-08-31 1990-05-15 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5008116A (en) * 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere
JPH08225454A (ja) * 1995-02-23 1996-09-03 Chugai Pharmaceut Co Ltd マイクロスフェア製剤

Also Published As

Publication number Publication date
ES2207123T3 (es) 2004-05-16
EP1060741A1 (de) 2000-12-20
DE69910987T2 (de) 2004-05-19
EP1060741B1 (de) 2003-09-03
ATE248587T1 (de) 2003-09-15

Similar Documents

Publication Publication Date Title
DE69910987D1 (de) Mikrosphären mit verzögerter Wirkstoffabgabe
USD440361S1 (en) Selective bird feeder
GEP20022707B (en) Biodegrading Macromers for the Controlled Release of Biologically Active Substances
EP1707563A3 (de) Chinazolinone Benutzende Verfahren und Zusammenstellungen
AU4467400A (en) Wear-resistant polymeric articles and methods of making the same
CA2340221A1 (en) Injectable formulations of nanoparticulate naproxen
ZA982159B (en) Administration of an injectable antibiotic in the ear of an animal.
ITFI930185A0 (it) Struttura di appoggio costituita da una pluralita' di elementi mobili per sedie, letti e simili.
EP0922715B8 (de) Via Keto-Enol-Tautomerie auf Stimuli reagierendes Polymer
ZA200204603B (en) Amphiphilic polymers and polypeptide conjugates comprising same.
USD448126S1 (en) Selective bird feeder
ZA200105746B (en) Coated candy products.
HK1037144A1 (en) Controlled release composition comprising a sustained release layer and a fast release layer.
ZA200003511B (en) Pharmaceutical tablet comprising an nsaid and misoprostol.
GB2372507B (en) Electroluminescent polymer having fluorene pendant and electroluminescent device using the same
AU7931500A (en) Device for diffusing in the soil volatile treating products
EP0683031A3 (de) Verfahren zum Herstellen mehrteiliger Spritzguss-Formteile und Werkzeug zur Durchführung des Verfahrens.
EP0859597A4 (de)
HUP0003076A3 (en) 3-cyano-2,4,5-trifluoro-benzoyl fluoride and intermediate products for the production thereof
DE69713586T2 (de) Dosisformen und deren verwendungen
AU7003096A (en) Semi-finished product for producing drug bases, bases obtained using the same and variants, and drugs obtained using these bases and variants
DE29721152U1 (de) Brot-Snack mit periodisch strukturierter Oberseite, sowie eine Vorrichtung zur Herstellung desselben
AU2581400A (en) An arrangement for distributing and despatching traffic in network, especiallyh.323 generated traffic
USD472020S1 (en) Profile of an aquarium base
USD436392S1 (en) Double sand trough playground equipment

Legal Events

Date Code Title Description
8364 No opposition during term of opposition